Both in Pharmaceuticals
Madrigal Pharmaceuticals vs Cytokinetics
Over the past year MDGL returned −3.9% and CYTK returned +3.8%; their daily moves had a correlation of 0.24.
MDGL −3.9% CYTK +3.8%Growth of $1, one year, split-adjusted
| Metric | MDGL | CYTK |
|---|---|---|
| Price | $396.32 | $62.31 |
| Market cap | $9.16B | $8.66B |
| Today | −8.08% | +0.45% |
| 1 month | −19.7% | −0.6% |
| 6 months | −21.1% | −19.2% |
| Year to date | −31.9% | −1.9% |
| 1 year | −5.4% | −2.0% |
| Revenue growth (YoY) | +71.2% | −57.1% |
| Gross margin | 100.0% | 90.5% |
| Net margin | −15.9% | −694.4% |
| P/E (TTM) | — | — |
| Price / sales | 7.1× | 128.0× |
| Net cash | $498.0M | $18.6M |
| Dividend yield | — | — |
| Volatility (60d) | 35.1% | 31.7% |
| Short % of float | 14.7% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).